Literature DB >> 11144670

Genetics of energetics: transcriptional responses in cardiac metabolism.

H Taegtmeyer1.   

Abstract

Recent evidence suggests that energy substrate metabolism forms the link between gene expression and contractile function of the heart. This hypothesis draws on three seemingly unconnected observations, made in 1941 by three different investigators. The first gave rise to the concept of the dynamic nature of body constituents, the second to the concept of one gene for one enzyme, and the third to the concept of energy conservation in the phosphate bond of adenosine triphosphate (ATP), the "approximate P." The heart employs different mechanisms to adapt to acute and to sustained changes in energy demand. While acute changes in energy demand are met by the coordinated activation or inactivation of enzymes, chronic changes in energy demand are met by adjustments in the rate of "metabolic" gene expression which are often isoform specific. Transcriptional analysis by quantitative polymerase chain reaction (PCR) defines changes in energy substrate metabolism in response to an altered physiologic environment at the transcriptional level. The paradigm of cardiac hypertrophy and atrophy has revealed a surprisingly uniform and rapid response in cardiac gene expression including the reactivation of fetal metabolic genes. The physiologic consequences are revealed in a shift in substrate utilization from fatty acids to glucose. Clinical consequences include a change in metabolic gene expression of the failing human heart, including the downregulation of glucose transporters and the enzymes of fatty acid metabolism. Although it is possible to study regulation of metabolism at the level of gene expression, the complexities of the interactions between metabolic intermediates and transcription factors may be difficult to elucidate by simple reductionist approaches. A model of feedback/feedforward between genes and proteins is needed to explain the principle of reestablishing homeostatic control of metabolism as cellular and external environments change.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11144670     DOI: 10.1114/1.1312187

Source DB:  PubMed          Journal:  Ann Biomed Eng        ISSN: 0090-6964            Impact factor:   3.934


  16 in total

1.  Mapping hypoxia-induced bioenergetic rearrangements and metabolic signaling by 18O-assisted 31P NMR and 1H NMR spectroscopy.

Authors:  Darko Pucar; Petras P Dzeja; Peter Bast; Richard J Gumina; Carmen Drahl; Lynette Lim; Nenad Juranic; Slobodan Macura; Andre Terzic
Journal:  Mol Cell Biochem       Date:  2004 Jan-Feb       Impact factor: 3.396

Review 2.  Metabolic stress in the myocardium: adaptations of gene expression.

Authors:  Peter A Crawford; Jean E Schaffer
Journal:  J Mol Cell Cardiol       Date:  2012-06-21       Impact factor: 5.000

Review 3.  The metabolic syndrome and the heart--a considered opinion.

Authors:  J G Leichman; V R Lavis; D Aguilar; C R Wilson; H Taegtmeyer
Journal:  Clin Res Cardiol       Date:  2006-01       Impact factor: 5.460

4.  Ketone bodies disturb fatty acid handling in isolated cardiomyocytes derived from control and diabetic rats.

Authors:  Danny M Hasselbaink; Jan F C Glatz; Joost J F P Luiken; Theo H M Roemen; Ger J Van der Vusse
Journal:  Biochem J       Date:  2003-05-01       Impact factor: 3.857

Review 5.  Taking pressure off the heart: the ins and outs of atrophic remodelling.

Authors:  Kedryn K Baskin; Heinrich Taegtmeyer
Journal:  Cardiovasc Res       Date:  2011-02-25       Impact factor: 10.787

6.  Myocardial oxygen consumption change predicts left ventricular relaxation improvement in obese humans after weight loss.

Authors:  C Huie Lin; Suraj Kurup; Pilar Herrero; Kenneth B Schechtman; J Christopher Eagon; Samuel Klein; Víctor G Dávila-Román; Richard I Stein; Gerald W Dorn; Robert J Gropler; Alan D Waggoner; Linda R Peterson
Journal:  Obesity (Silver Spring)       Date:  2011-07-07       Impact factor: 5.002

7.  Normalization of cardiac substrate utilization and left ventricular hypertrophy precede functional recovery in heart failure regression.

Authors:  Nikole J Byrne; Jody Levasseur; Miranda M Sung; Grant Masson; Jamie Boisvenue; Martin E Young; Jason R B Dyck
Journal:  Cardiovasc Res       Date:  2016-03-10       Impact factor: 10.787

Review 8.  AMPK alterations in cardiac physiology and pathology: enemy or ally?

Authors:  Jason R B Dyck; Gary D Lopaschuk
Journal:  J Physiol       Date:  2006-05-11       Impact factor: 5.182

9.  Endogenous ghrelin increases in adriamycin-induced heart failure rats.

Authors:  Z Xu; W Wu; X Zhang; G Liu
Journal:  J Endocrinol Invest       Date:  2007-02       Impact factor: 4.256

10.  The role of nuclear imaging in pulmonary hypertension.

Authors:  H Ohira; R S Beanlands; R A Davies; L Mielniczuk
Journal:  J Nucl Cardiol       Date:  2014-08-27       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.